Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan. (Q54531262)
Jump to navigation
Jump to search
scientific article published in June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan. |
scientific article published in June 2012 |
Statements
Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan. (English)
1 reference
Masakazu Toi
1 reference
Masahide Kondo
1 reference
Shu-Ling Hoshi
1 reference
Hiroshi Ishiguro
1 reference
1 June 2012
1 reference
133
1 reference
759-768
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference